Next Article in Journal
A Preliminary Study on Factors That Drive Patient Variability in Human Subcutaneous Adipose Tissues
Previous Article in Journal
Synovium-Derived and Bone-Derived Mesenchymal Stem/Stromal Cells from Early OA Patients Show Comparable In Vitro Properties to Those of Non-OA Patients
Previous Article in Special Issue
Renal Ischemia Induces Epigenetic Changes in Apoptotic, Proteolytic, and Mitochondrial Genes in Swine Scattered Tubular-like Cells
 
 
Correction to Cells 2022, 11(1), 90.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Santos et al. The Mitochondrial Antioxidant Sirtuin3 Cooperates with Lipid Metabolism to Safeguard Neurogenesis in Aging and Depression. Cells 2022, 11, 90

1
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal
2
Instituto de Medicina Molecular (iMM) João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal
3
Department of Translational Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany
4
Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal
*
Authors to whom correspondence should be addressed.
Cells 2024, 13(15), 1239; https://doi.org/10.3390/cells13151239
Submission received: 27 June 2024 / Accepted: 3 July 2024 / Published: 24 July 2024
(This article belongs to the Special Issue Mitochondrial Functions in Stem Cells)

Error in Figure

In the original article [1], there was a mistake in Figure 4B (upper right panels) as published. By mistake, the representative images of SA-β-gal staining in neural stem cells of the control condition became overlapped with the representative figures of SIRT3 overexpression. The corrected Figure 4B (upper right panels) appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Santos, S.S.; Moreira, J.B.; Costa, M.; Rodrigues, R.S.; Sebastião, A.M.; Xapelli, S.; Solá, S. The Mitochondrial Antioxidant Sirtuin3 Cooperates with Lipid Metabolism to Safeguard Neurogenesis in Aging and Depression. Cells 2022, 11, 90. [Google Scholar] [CrossRef] [PubMed]
Figure 4. SIRT3 requires LCAD and oxidative control to prevent NSC aging. Mouse NSCs were treated with 50 μM tBHP for 2 h/day, for 4 consecutive days, in self-renewal conditions. At day 2 post-plating, cells were co-transfected with SIRT3 overexpression plasmid and siRNA LCAD, and 48 h afterwards cells were collected for analysis, as described in Section 2. Senescence staining protocol was performed 24 h before the last treatment. (A) qRT-PCR analysis of differentiation marker MAP2 and lipid accumulation marker PLIN2. Hprt was used as loading control. Data are expressed as fold change over control or siRNA LCAD groups (reference conditions, no tBHP added). (B) Representative images of SA-β-gal staining in NSCs exposed to tBHP treatment for 4 days (control group, no tBHP added), and subjected to SIRT3 overexpression, with or without additional LCAD silencing. H2O2 overnight treatment served as a positive control. Scale bar: 100 μm. Lower panels: selected sections enlarged 4×. (C) Quantitative analysis of cells positive for SA-β-gal for a given group, expressed as the percentage of the total number of cells. (A,C) Data represent mean values ± SEM for three independent experiments, yielding at least 7 data points per group. Each data point represents an individual value. ** p < 0.01 and *** p < 0.001 compared to control cells, § p < 0.05 and §§§ p < 0.001 compared to tBHP-treated cells,  p < 0.05 compared to SIRT3-transfected cells, and  p < 0.001 compared to SIRT3-transfected cells with or without tBHP treatment. Abbreviations: LCAD, long chain acyl-CoA dehydrogenase; MAP2, microtubule-associated protein 2; PLIN2, perilipin 2; SA-β-GAL, SA-β-galactosidase; siLCAD, LCAD silencing; tBHP, tert-butyl hydroperoxide.
Figure 4. SIRT3 requires LCAD and oxidative control to prevent NSC aging. Mouse NSCs were treated with 50 μM tBHP for 2 h/day, for 4 consecutive days, in self-renewal conditions. At day 2 post-plating, cells were co-transfected with SIRT3 overexpression plasmid and siRNA LCAD, and 48 h afterwards cells were collected for analysis, as described in Section 2. Senescence staining protocol was performed 24 h before the last treatment. (A) qRT-PCR analysis of differentiation marker MAP2 and lipid accumulation marker PLIN2. Hprt was used as loading control. Data are expressed as fold change over control or siRNA LCAD groups (reference conditions, no tBHP added). (B) Representative images of SA-β-gal staining in NSCs exposed to tBHP treatment for 4 days (control group, no tBHP added), and subjected to SIRT3 overexpression, with or without additional LCAD silencing. H2O2 overnight treatment served as a positive control. Scale bar: 100 μm. Lower panels: selected sections enlarged 4×. (C) Quantitative analysis of cells positive for SA-β-gal for a given group, expressed as the percentage of the total number of cells. (A,C) Data represent mean values ± SEM for three independent experiments, yielding at least 7 data points per group. Each data point represents an individual value. ** p < 0.01 and *** p < 0.001 compared to control cells, § p < 0.05 and §§§ p < 0.001 compared to tBHP-treated cells,  p < 0.05 compared to SIRT3-transfected cells, and  p < 0.001 compared to SIRT3-transfected cells with or without tBHP treatment. Abbreviations: LCAD, long chain acyl-CoA dehydrogenase; MAP2, microtubule-associated protein 2; PLIN2, perilipin 2; SA-β-GAL, SA-β-galactosidase; siLCAD, LCAD silencing; tBHP, tert-butyl hydroperoxide.
Cells 13 01239 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Santos, S.S.; Moreira, J.B.; Costa, M.; Rodrigues, R.S.; Sebastião, A.M.; Xapelli, S.; Solá, S. Correction: Santos et al. The Mitochondrial Antioxidant Sirtuin3 Cooperates with Lipid Metabolism to Safeguard Neurogenesis in Aging and Depression. Cells 2022, 11, 90. Cells 2024, 13, 1239. https://doi.org/10.3390/cells13151239

AMA Style

Santos SS, Moreira JB, Costa M, Rodrigues RS, Sebastião AM, Xapelli S, Solá S. Correction: Santos et al. The Mitochondrial Antioxidant Sirtuin3 Cooperates with Lipid Metabolism to Safeguard Neurogenesis in Aging and Depression. Cells 2022, 11, 90. Cells. 2024; 13(15):1239. https://doi.org/10.3390/cells13151239

Chicago/Turabian Style

Santos, Sónia Sá, João B. Moreira, Márcia Costa, Rui S. Rodrigues, Ana M. Sebastião, Sara Xapelli, and Susana Solá. 2024. "Correction: Santos et al. The Mitochondrial Antioxidant Sirtuin3 Cooperates with Lipid Metabolism to Safeguard Neurogenesis in Aging and Depression. Cells 2022, 11, 90" Cells 13, no. 15: 1239. https://doi.org/10.3390/cells13151239

APA Style

Santos, S. S., Moreira, J. B., Costa, M., Rodrigues, R. S., Sebastião, A. M., Xapelli, S., & Solá, S. (2024). Correction: Santos et al. The Mitochondrial Antioxidant Sirtuin3 Cooperates with Lipid Metabolism to Safeguard Neurogenesis in Aging and Depression. Cells 2022, 11, 90. Cells, 13(15), 1239. https://doi.org/10.3390/cells13151239

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop